David Canner

Insider Reports History

Location
C/O Soleus Capital Management, L.P., 104 Field Point Road, Second Floor, Greenwich, CT
Signature
/s/ David McIntyre, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Canner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inhibikase Therapeutics, Inc. Director Stock Option (Right to Buy) 108K Jun 30, 2025 Direct

Insider Reports Filed by David Canner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IKT Inhibikase Therapeutics, Inc. Jun 30, 2025 1 $0 4 Jul 2, 2025 Director
IKT Inhibikase Therapeutics, Inc. Feb 14, 2025 2 $0 4 Feb 19, 2025 Director
IKT Inhibikase Therapeutics, Inc. Oct 21, 2024 1 $0 4 Oct 23, 2024 Director
IKT Inhibikase Therapeutics, Inc. Oct 21, 2024 0 $0 3 Oct 23, 2024 Director